Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease

被引:91
|
作者
Ferrari, Laura [1 ,2 ]
Huang, Su-Chun [3 ]
Magnani, Giuseppe [1 ,2 ]
Ambrosi, Alessandro [3 ]
Comi, Giancarlo [1 ,2 ,3 ]
Leocani, Letizia [1 ,2 ,3 ]
机构
[1] Ist Sci San Raffaele, Dept Neurol, Milan, Italy
[2] Ist Sci San Raffaele, Inst Expt Neurol, INSPE, Milan, Italy
[3] Univ Vita Salute San Raffaele, Milan, Italy
关键词
Alzheimer's disease; frontotemporal dementia; ganglion cell layer; optical coherence tomography; retinal nerve fiber layer; NERVE-FIBER LAYER; MILD COGNITIVE IMPAIRMENT; MOUSE MODEL; THICKNESS; DEGENERATION; PATHOLOGY; ABNORMALITIES; GUIDELINES; DIAGNOSIS; BIOMARKER;
D O I
10.3233/JAD-160886
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Alzheimer's disease (AD) and frontotemporal dementia (FTD) are leading causes of cognitive decline. Optical coherence tomography (OCT) allows the measurement of thickness of retinal neuroaxonal layers. While in AD and mild cognitive impairment (MCI), retinal nerve fiber layer (RNFL) thinning is frequently reported, less information is available on ganglion cell layer-inner plexiform layer (GCL-IPL). Data on FTD are lacking. Objective: To obtain cross-sectional information on RNFL and GCL-IPL thickness among MCI, AD, FTD, and healthy controls (HC), and their correlations with dementia severity. Methods: Peripapillary OCT scans were obtained in 27 MCI, 39 AD, 17 FTD, 49 HC using high-definition Heidelberg Spectral-domain OCT, with RNFL and GCL-IPL thickness measurement. Statistical analysis tested group effects and correlation with gender, disease duration and severity (Mini-Mental State Examination, MMSE). Results: RNFL showed a significant group effect [F(4,132) = 3.786, p = 0.006], being reduced versus controls in MCI (p = 0.033), moderate AD (p = 0.025), and FTD (p < 0.001), and versus mild AD in FTD (p = 0.042). GCL-IPL showed a significant group effect as well [F(4,121) = 5.104, p < 0.001], with reduction in moderate AD versus HC (p < 0.001), MCI (p = 0.037), and mild AD (p = 0.009); in FTD versus HC (p = 0.002) and mild AD (p = 0.038). In AD, GCL-IPL correlated with MMSE (r = 0.487, p = 0.003), without significant effects of age, gender, or disease duration. Conclusion: Retinal neuroaxonal thinning occurs in MCI/AD consistently with previous reports, as well as in FTD. Correlation with disease severity in AD suggests that retinal and brain neurodegeneration may occur in parallel to some extent, and prompts larger studies aimed at providing surrogate endpoints for clinical trials in AD.
引用
收藏
页码:1101 / 1107
页数:7
相关论文
共 50 条
  • [41] RETINAL NEURODEGENERATION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE AN OPTICAL COHERENCE TOMOGRAPHY STUDY
    Olcucuoglu, Leyli Can Aynal
    Munis, Ozlem Bizpinar
    Guven, Huriye Hayat
    Eraslan, Numan
    Celikay, Osman
    Comoglu, Selim Selcuk
    TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2021, 24 (02): : 185 - 195
  • [42] Reliability and validity of Cirrus and Spectralis optical coherence tomography for detecting retinal atrophy in Alzheimer’s disease
    V Polo
    E Garcia-Martin
    M P Bambo
    J Pinilla
    J M Larrosa
    M Satue
    S Otin
    L E Pablo
    Eye, 2014, 28 : 680 - 690
  • [43] Retinal microvascular attenuation in mental cognitive impairment and Alzheimer's disease by optical coherence tomography angiography
    Wu, Jing
    Zhang, Xiaojun
    Azhati, Guliqiwaer
    Li, Tingting
    Xu, Guoxing
    Liu, Fang
    ACTA OPHTHALMOLOGICA, 2020, 98 (06) : E781 - E787
  • [44] Retinal Nerve Fiber Layer Thinning in Dementia Associated with Parkinson's Disease, Dementia with Lewy Bodies, and Alzheimer's Disease
    Moreno-Ramos, Teresa
    Benito-Leon, Julian
    Villarejo, Alberto
    Bermejo-Pareja, Felix
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 34 (03) : 659 - 664
  • [45] Retinal thinning in psychosis spectrum disorders: optical coherence tomography findings
    Jerotic, S.
    Ristic, I.
    Ignjatovic, Z.
    Maric, N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 31 : S54 - S55
  • [46] Alzheimer disease and frontotemporal dementia
    Rozzini, L
    Lussignoli, G
    Padovani, A
    Bianchetti, A
    Trabucchi, M
    ARCHIVES OF NEUROLOGY, 1997, 54 (04) : 350 - 350
  • [47] Animal models of Alzheimer's disease and frontotemporal dementia
    Jürgen Götz
    Lars M. Ittner
    Nature Reviews Neuroscience, 2008, 9 : 532 - 544
  • [48] Amygdaloid atrophy in frontotemporal dementia and Alzheimer's disease
    Boccardi, M
    Pennanen, C
    Laakso, MP
    Testa, C
    Geroldi, C
    Soininen, H
    Frisoni, GB
    NEUROSCIENCE LETTERS, 2002, 335 (02) : 139 - 143
  • [49] The molecular basis of Alzheimer's disease and frontotemporal dementia
    Kwok, JBJ
    Schofield, PR
    AGEING BRAIN: THE NEUROBIOLOGY AND NEUROPSYCHIATRY OF AGEING, 2003, : 173 - 185
  • [50] A comparison of unawareness in frontotemporal dementia and Alzheimer's disease
    Salmon, E.
    Perani, D.
    Collette, F.
    Feyers, D.
    Kalbe, E.
    Holthoff, V.
    Sorbi, S.
    Herholz, K.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (02): : 176 - 179